Swen M. John

Oct 8, 2023 | onlinelibrary.wiley.com | Matthias Augustin |Swen M. John

In this issue of JEADV, Gisondi et al.1 address one of the key topics in global dermatology: the disease burden from the patient's perspective. Burden was operationalized by measuring health-related quality of life (QoL) with the validated Dermatology Life Quality Index (DLQI); other constructs were assessed using non-validated single items, such as for depression, work impairment and stigmatization.